FibroBiologics (FBLG) Financials: Revenue & Earnings
FBLG$0.97+0.04 +4.11%
$6.46M
Market Cap
—
P/E
—
Forward P/E
—
Score
FibroBiologics (FBLG) Financials: Revenue & Earnings
FBLG price $0.97 +0.04 +4.11%
- Ticker
- FBLG
- Price
- $0.97
- Change
- +0.04 +4.11%
- Market cap ?
- $6.46M
- Beta ?
- 1.22
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
FBLG fair value Not meaningful. Price $0.97.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-10-30 | — | -0.63 | — | — |
| 2026-07-31 | -0.66 | -0.93 | — | — |
| 2026-04-30 | -1.33 | -1.26 | — | — |
| 2026-02-24 | -0.98 | -1.44 | — | — |
| 2025-10-31 | -2.60 | -2.00 | — | — |
| 2025-07-31 | -2.40 | -0.11 | — | — |
| 2025-05-14 | -2.80 | -2.00 | — | — |
| 2025-03-27 | -1.80 | -0.10 | — | — |
| 2024-11-12 | -0.20 | -1.44 | — | — |
| 2024-08-07 | 0.60 | -0.09 | — | — |
| 2024-05-14 | -5.40 | — | — | — |
| 2024-02-29 | -6.20 | — | — | — |
| 2023-09-30 | -0.07 | — | — | — |
| 2023-06-30 | -0.07 | — | — | — |
| 2023-03-31 | -0.07 | — | — | — |
| 2022-12-31 | -0.05 | — | — | — |
| 2022-09-29 | -0.05 | — | — | — |
| 2022-06-30 | -0.04 | — | — | — |
| 2022-03-31 | -0.04 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-09-15 | Khoja Hamid | Buy | 298.51K | $1.68 | 500.00K |
| 2026-09-15 | Khoja Hamid | Buy | 298.51K | $1.55 | 462.69K |
| 2026-08-20 | Steinberg Leigh | Other | 0 | — | — |
| 2026-07-08 | Rubins Kathleen Hallisey | Other | 562 | $65.60 | 36.87K |
| 2026-06-23 | Hoffman Robert E. | Buy | 30.80K | $0.75 | 23.11K |
| 2026-06-23 | Cilento Richard C. Jr. | Buy | 30.80K | $0.75 | 23.11K |
| 2026-06-23 | Link Matthew | Buy | 30.80K | $0.75 | 23.11K |
| 2026-06-23 | Niklas Victoria Ninon Olivia | Buy | 30.80K | $0.75 | 23.11K |
| 2026-05-04 | O'HEERON PETE | Buy | 92.41K | $1.38 | 127.53K |
| 2026-05-04 | Khoja Hamid | Buy | 61.61K | $1.38 | 85.02K |
| 2026-05-04 | Davis Jason | Buy | 61.61K | $1.38 | 85.02K |
| 2026-05-04 | GARCIA RUBEN A | Buy | 61.61K | $1.38 | 85.02K |
| 2026-03-04 | Khoja Hamid | Buy | 30.00K | $0.38 | 11.40K |
| 2026-03-04 | O'HEERON PETE | Buy | 15.87K | $0.38 | 6.01K |
| 2026-03-03 | O'HEERON PETE | Buy | 18.20K | $0.41 | 7.37K |
| 2026-03-02 | O'HEERON PETE | Buy | 17.43K | $0.35 | 6.15K |
| 2026-03-02 | Davis Jason | Buy | 70.00K | $0.41 | 28.97K |
| 2026-02-27 | GARCIA RUBEN A | Buy | 40.00K | $0.33 | 13.06K |
| 2025-12-11 | GARCIA RUBEN A | Buy | 140.00K | $0.34 | 47.60K |
| 2025-06-12 | Niklas Victoria Ninon Olivia | Buy | 22.00K | $0.87 | 19.20K |
| 2025-06-12 | Link Matthew | Buy | 22.00K | $0.87 | 19.20K |
| 2025-06-12 | Hoffman Robert E. | Buy | 22.00K | $0.87 | 19.20K |
| 2025-06-12 | Coen Stacy Ann | Buy | 22.00K | $0.87 | 19.20K |
| 2025-06-12 | Cilento Richard C. Jr. | Buy | 22.00K | $0.87 | 19.20K |
| 2025-06-09 | Davis Jason | Buy | 450.00K | $0.94 | 425.16K |
| 2025-06-09 | Davis Jason | Other | 0 | — | — |
| 2025-05-27 | Khoja Hamid | Buy | 20.00K | $0.84 | 16.80K |
| 2025-03-26 | O'HEERON PETE | Buy | 453.00K | $1.04 | 471.12K |
| 2025-03-26 | GARCIA RUBEN A | Buy | 189.00K | $1.04 | 196.56K |
| 2025-03-26 | Khoja Hamid | Buy | 189.00K | $1.04 | 196.56K |
| 2024-12-27 | O'HEERON PETE | Buy | 406.34K | $2.36 | 958.96K |
| 2024-12-27 | Khoja Hamid | Buy | 176.20K | $2.36 | 415.83K |
| 2024-12-27 | GARCIA RUBEN A | Buy | 176.20K | $2.36 | 415.83K |
| 2024-12-09 | O'HEERON PETE | Sell | 100.00K | — | — |
| 2024-12-03 | O'HEERON PETE | Sell | 50.00K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 16, holders -1 vs prior quarter. Ownership 7.55%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CASCADE FINANCIAL PARTNERS, LLC | 108.83K | 108.83K | New | 103.14K |
| FUND EVALUATION GROUP, LLC | 51.79K | 0 | 0.00% | 49.09K |
| GEODE CAPITAL MANAGEMENT, LLC | 30.30K | 30.30K | New | 28.72K |
| VANGUARD CAPITAL MANAGEMENT LLC | 27.77K | -39.90K | -58.96% | 26.32K |
| QUBE RESEARCH & TECHNOLOGIES LTD | 24.31K | 24.31K | New | 23.04K |
| BLACKROCK, INC. | 18.24K | 18.24K | New | 17.28K |
| BARCLAYS PLC | 7.24K | 7.24K | New | 6.86K |
| VANGUARD FIDUCIARY TRUST CO | 6.38K | 0 | 0.00% | 6.05K |
| TOWER RESEARCH CAPITAL LLC (TRC) | 4.73K | 4.73K | New | 4.48K |
| OSAIC HOLDINGS, INC. | 2.40K | 2.40K | New | 2.28K |
| UBS GROUP AG | 1.07K | 1.07K | New | 1.02K |
| ROYAL BANK OF CANADA | 1.52K | 1.52K | New | 1.00K |
| ISLAY CAPITAL MANAGEMENT, LLC | 169 | 169 | New | 160 |
| GROVE BANK & TRUST | 100 | 100 | New | 95 |
| BNP PARIBAS FINANCIAL MARKETS | 64 | 64 | New | 61 |
| ALLWORTH FINANCIAL LP | 13 | 13 | New | 13 |
| VANGUARD GLOBAL ADVISERS, LLC | 0 | -536 | -100.00% | 0 |
| RENAISSANCE TECHNOLOGIES LLC | 0 | — | — | 0 |
| NEWEDGE ADVISORS, LLC | 0 | — | — | 0 |
| WELLS FARGO & COMPANY/MN | 0 | — | — | 0 |
| WESTERN WEALTH MANAGEMENT, LLC | 0 | -200 | -100.00% | 0 |
Earnings and financials
FibroBiologics, Inc. Common Stock (FBLG) trades at $0.97, with a market cap of $6.46M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn